Items in cart [1] Questions? Call 888-624-8373

PAPERBACK list:$30.25 Web:$27.23 add to cart Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters Display this book on your site! Related Titles From Cancer Patient to Cancer Survivor: Lost in Transition Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment Other Related Titles Diffusion and Use of Genomic Innovations in Health and Medicine: Workshop Summary (2008) Board on Health Sciences Policy (HSP) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 89   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix A Workshop Agenda Roundtable on Translating Genomic-Based Research for Health Board on Health Sciences Policy Tuesday, December 4, 2007 Agenda Workshop on Diffusion and Use of Genomic Innovations in Health and Medicine Auditorium National Academies Building 2101 Constitution Avenue, NW Washington, DC 20001 8:30-8:40 Welcome and Overview of Workshop   WYLIE BURKE Roundtable Chair Professor and Chair Department of Medical History and Ethics University of Washington School of Medicine Page 89 Front Matter (R1-R16) 1 Introduction (1-2) 2 Translation of Innovations (3-24) 3 Practical Incentives and Barriers to Translation (25-46) 4 Translation of Genomic Technology at the Clinical Level (47-64) 5 Opportunities and Constraints for Translation of Genomic Innovations (65-80) 6 Concluding Remarks (81-84) References (85-88) Appendix A: Workshop Agenda (89-92) Appendix B: Biographical Sketches of the Workshop Speakers (93-100)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 89
Diffusion and Use of Genomic Innovations in Health and Medicine: Workshop Summary Appendix A Workshop Agenda Roundtable on Translating Genomic-Based Research for Health Board on Health Sciences Policy Tuesday, December 4, 2007 Agenda Workshop on Diffusion and Use of Genomic Innovations in Health and Medicine Auditorium National Academies Building 2101 Constitution Avenue, NW Washington, DC 20001 8:30-8:40 Welcome and Overview of Workshop   WYLIE BURKE Roundtable Chair Professor and Chair Department of Medical History and Ethics University of Washington School of Medicine

OCR for page 90
Diffusion and Use of Genomic Innovations in Health and Medicine: Workshop Summary 8:40-10:00 Panel on Translation of Innovations 8:40-9:00 Translation of Innovations: A Broad Perspective   ROBERT CALIFF Vice Chancellor for Clinical Research Professor of Medicine Duke University 9:00-9:20 Innovation: Understanding Types of Innovation and Implications for Policy   KEVIN SCHULMAN Professor, Medicine and Business Administration Director, Center for Clinical and Genetic Economics Associate Director, Duke Clinical Research Institute Duke University 9:20-9:40 Technologic Diffusion: Lessons for Genomics from Other Technologies   ANNETINE GELIJNS Professor, Health Policy, Management, and Surgical Science Co-Director, International Center for Health Outcomes and Innovation Research Columbia University 9:40-10:00 Discussion 10:00-10:20 BREAK 10:20-12:00 Panel on Practical Incentives and Barriers to Translation 10:20-10:40 Translating Medical Innovations with Appropriate Evidence   SEAN TUNIS Founder and Director Center for Medical Technology Policy

OCR for page 91
Diffusion and Use of Genomic Innovations in Health and Medicine: Workshop Summary 10:40-11:00 Assessing Technology for Use in Health and Medicine   NAOMI ARONSON Executive Director, Technology Evaluation Center Blue Cross and Blue Shield Association 11:00-11:20 Integrating Genetic Technology into a Health Care System   WYLIE BURKE Roundtable Chair Professor and Chair Department of Medical History and Ethics University of Washington School of Medicine 11:20-11:40 View from the Trenches: Challenges and Opportunities in Personalized Medicine   BRAD GRAY Vice President of Business and Strategic Development Genzyme Genetics 11:40-12:00 Discussion 12:00-1:00 LUNCH 1:00-2:30 Panel on Translation of Genomic Technology at the Clinical Level 1:00-1:30 A Primary Care Provider View of Translating Genomic Innovation   ALFRED BERG Professor University of Washington 1:30-2:00 Introducing a Genomic Innovation to Clinical Practice   STEVEN SHAK Chief Medical Officer Genomic Health 2:00-2:30 Discussion

OCR for page 92
Diffusion and Use of Genomic Innovations in Health and Medicine: Workshop Summary 2:30-2:50 BREAK 2:50-4:00 Panel on Opportunities and Constraints for Translation of Genomic Innovations 2:50-3:10 The Global Perspective   STUART HOGARTH Research Associate Department of Public Health and Primary Care University of Cambridge 3:10-3:30 The U.S. Perspective   DEBORAH MARSHALL Professor, McMaster University Vice President, Global Health Economics and Outcomes i3 Innovus 3:30-4:00 Discussion 4:00-4:30 Summing Up   WYLIE BURKE Roundtable Chair Professor and Chair Department of Medical History and Ethics University of Washington School of Medicine 4:30 ADJOURN WORKSHOP